Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine
Open Access
- 15 January 2003
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (2) , 169-174
- https://doi.org/10.1086/345668
Abstract
A substudy analysis was conducted to determine the clinical characteristics associated with symptomatic, laboratory-documented influenza (LDI) among 2215 veterans with chronic obstructive pulmonary disease who participated in Department of Veterans Affairs Cooperative Study 448 and who received trivalent inactivated influenza virus vaccine with or without intranasal live-attenuated, cold-adapted influenza vaccine. Of 585 evaluable first occurrences of acute respiratory illnesses, 94 (16%) were LDI. Respiratory symptoms of cough, sputum production, and dyspnea occurred in >90% of patients with LDI; 68% had documented or subjective fever, and 81% had myalgias. Stepwise logistic regression identified only fever and myalgia as being statistically associated with LDI. During the influenza outbreak period, the positive predictive value of fever and myalgia was 41%. Clinical criteria were poor predictors of LDI in these older, vaccinated patients with chronic lung disease. Additional studies are warranted to define optimal methods for the diagnosis of influenza among older persons with chronic obstructive pulmonary disease.Keywords
This publication has 25 references indexed in Scilit:
- Clinical Signs and Symptoms Predicting Influenza InfectionArchives of internal medicine (1960), 2000
- Predicting Influenza Infections during Epidemics with Use of a Clinical Case DefinitionClinical Infectious Diseases, 2000
- Respiratory Viral Infections in Adults With and Without Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997
- Respiratory Syncytial Virus and Influenza A Infections in the Hospitalized ElderlyThe Journal of Infectious Diseases, 1995
- Control of Influenza Outbreaks in the Nursing Home: Guidelines for Diagnosis and ManagementJournal of the American Geriatrics Society, 1995
- The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trialJAMA, 1994